Product Images Tarceva

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Tarceva NDC 50242-064 by Genentech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 01

image 01

image 02

image 02

This appears to be a chart or graph showing the progression-free survival probability for patients receiving chemotherapy versus Tarceva. It includes the number of patients at risk and the duration of progression-free survival in months. Without more context, it is difficult to provide a more detailed description or interpretation.*

image 03

image 03

This appears to be a table or graph showing the results of a study comparing the effectiveness of a placebo versus a drug called TARCEVA on survival rates of patients. The table includes the number of patients at risk and overall survival in months for each group over time.*

image 04

image 04

image 05

image 05

image 06

image 06

image 07

image 07

This is a description of a drug called Tarceva, which comes in the form of tablets. It is manufactured by Osi Pharmaceuticals and distributed by Genentech, a member of the Roche Group. Each tablet contains 25 mg of erlotinib free base. The drug is stored at 25°C (77°F), but can be permitted to 15°-30°C (59°-86°F) according to USP. The package insert includes complete prescription information. There is also trademark and copyright information on this label, as well as an area designated for printing LOT, EXP, and serialization information.*

image 08

image 08

This is a pharmaceutical product called Tarceva, erlotinib tablet. The package insert provides information on dosage and administration. The storage temperature for the drug is between 15°-30°C (59°-86°F). This drug is manufactured for OS| Pharmaceuticals LLC, Northbrook, IL 60062, affiliated with Astelas Pharma US, Inc., and distributed by Cenentech USA, Inc., a member of the Roche Group. Each tablet contains 100 mg of erlotinib-free base. The product's NDC number is 50242-063-01. There is also a trademark stated.*

image 09

image 09

Tarceva (erlotinib) Tablets contain 150 mg of erlotinib free base and are used for prescription-only purposes. The enclosed package contains complete prescribing information, including dosage, and administration guidelines. The recommended storage temperature is 25°C (77°F), with excursions permitted to a range of 15°-30°C (59°-86°F). The tablets are manufactured for 0| Pharmaceuticals, LLC, a company affiliated with Astelas Pharma US, Inc, and distributed by Genentech USA, Inc, a member of the Roche Group. The tablets come in a pack of 30 and have a registered trademark with NDC 50242-064-01. This text contains relevant information for use of the medicine, storage, and manufacturer details.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.